Schizophrenia and oral health: a literature review

Reza AGHASIZADEH SHERBAF; Katalin NAGY; Csaba BERKOVITS; Péter ÁLMOS; László PÁRKÁNYI; Zohreh AGHASSI ZADEH SHERBAF; Laura KOMLÓSI; George KAPOSVÁRI

doi:10.33891/FSZ.114.3.138-145

Reza AGHASIZADEH SHERBAF Faculty of Dentistry, Department of Oral Surgery, University of Szeged, Hungary https://orcid.org/0000-0002-1167-2684
Katalin NAGY Faculty of Dentistry, Department of Oral Surgery, University of Szeged, Hungary https://orcid.org/0000-0001-9383-5952
Csaba BERKOVITS Faculty of Dentistry, Department of Oral Surgery, University of Szeged, Hungary
Péter ÁLMOS Department of Psychiatry, Faculty of Medicine, University of Szeged, Hungary
László PÁRKÁNYI Department of Periodontology, Faculty of Dentistry, University of Szeged, Hungary
Zohreh AGHASSI ZADEH SHERBAF Emergency Dentistry Unit, Sorbonne University Hospital, Sorbonne, France
Laura KOMLÓSI Faculty of Dentistry, Department of Oral Surgery, University of Szeged, Hungary
George KAPOSVÁRI Faculty of Dentistry, Department of Oral Surgery, University of Szeged, Hungary

DOI: https://doi.org/10.33891/FSZ.114.3.138-145

Keywords: schizophrenia, oral hygiene, periodontal status, smoking, dental treatment, psychiatric disorders

Abstract

Medical disorders can affect dental health directly or indirectly. As psychiatric disorders are one of the most frequent diseases in dental patients, such patients form a special needs group, which require modifications and adjustments to the standard treatment protocols. Schizophrenia is a complex, chronic mental disorder, which involves behavioural and cognitive changes, disturbances in perceptions, and impairment of certain conscious functions. In its active phase, the symptoms include delusions, hallucinations, disorganized speech, and abnormal motor function. If a schizophrenic patient presents to a dental office, psychiatric consultation may be necessary. Usually, it is suggested that any elective dental treatment should be deferred until the patient’s symptoms are under control or in a state of inactivity. Side effects of the medications may affect the patient in an adverse way; thus, a careful monitoring by a psychiatrist is essential and forms a part of the recommended treatment approach. This paper will address a literature review of various concepts and recommendations for defining a suitable dental treatment plan for the patients with schizophrenia.

References

AGGARWAL A, KELUSKAR V: Physiotherapy as an adjuvant therapy for treatment of TMJ disorders.Gen Dent 2012; 60 (2): e119–22. PMID: 22414516.

ARNAIZ A, ZUMARRAGA M, DIEZ-ALTUNA I, et al: Oral helath and the symptoms of schizophrenia. Psychiatry Res 2011; 188 (1): 24-28. https://doi.org/10.1016/j.psychres.2010.09.012

ARORA M, WEUVE J, SCHWARTZ J, et al: Association of environmental cadmium exposure with periodontal disease in U.S. adults. Environ Health Perspect 2009; 117(5):739-755. https://doi.org/10.1289/ehp.0800312

AYUSO-MATEOS JL: Global burden of schizophrenia in the year 2000. World Health Organization. https://www.who.int/healthinfo/statistics/bod_schizophrenia.pdf (2021.04.12).

BECKER DE: Psychotropic Drugs: Implications For Dental Practice, Anesth Prog 2008; 55(3): 89–99. https://doi.org/10.2344/0003-3006-55.3.89

BHATT SH. Body odor. J. Am. Med. Assoc. 1995; 273:1171-1172.

BROWN S, GREENWOOD M, MEECHAN JG: General medicine and surgery for dental practitioners. Part 5 – Psychiatry. Br Dent J 2010; 209(1): 11-16. https://doi.org/10.1038/sj.bdj.2010.578

CHUONG R. Schizophrenia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:526-528. https://doi.org/10.1016/S1079-2104(99)70079-X

CLARK DB: Dental care for the psychiatric patient: chronic schizophrenia. J Can Dent Assoc 1992; 58(11): 912-916. PMID: 1292861

COCKBURN N, PRADHAN A, TAING MW, et al: Oral health impacts of medications used to treat mental illness. J Affect Disord 2017; 223: 184-193. https://doi.org/10.1016/j.jad.2017.07.037

DIOS DP, POSSE JL, CARMONA IT: Schizoprhenia and halitosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89(6):661. https://doi.org/10.1067/moe.2000.oe896661

ELTAS A, KARTALCI S, ELTAS SD, et al: An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication. Int J Dent Hyg 2013; 11(2): 78-83. https://doi.org/10.1111/j.1601-5037.2012.00558.x

ENOCH MD, JAGGER RG: Psychiatric disorders in dentistry. (1st ed.) Oxford, Boston, Wright, 1994; 1-5.

EVINS AE: Nicotine dependence in schizophrenia: prevalence, mechanisms, and implications for treatment. Psychiatric Times 2008. 25 (3). https://www.psychiatrictimes.com/view/nicotine-dependence-schizophrenia-prevalence-mechanisms-and-implications-treatment (2020.11.06).

FOULDS J, WILLIAMS J: Tobacco use and cataracts in patients with schizophrenia. Am J Psychiatry 2005; 162(5): 1028. https://doi.org/10.1176/appi.ajp.162.5.1028

FRIEDLANDER AH, BRILL NQ: The dental management of patients with schizophrenia. Spec Care Dentist 1986; 6(5): 217-218. https://doi.org/10.1111/j.1754-4505.1986.tb01002.x

FRIEDLANDER AH, FRIEDLANDER IK, YAGIELA JA, et al: Dental management of the child and adolescent with major depression. ASDC J Dent Child 1993; 60(2):125-131. PMID: 8486855.

FRIENDLANDER AH, LIBERMAN RP: Oral health care for the patient with schizophrenia. Spec Care Dentist 1991; 11(5): 179-183. https://doi.org/10.1111/j.1754-4505.1991.tb01726.x

GIRMA E, TESFAYE M: Patterns of treatment seeking behavior for mental illnesses in Southwest Ethiopia: a hospital based study. BMC Psychiatry 2011; 138. https://doi.org/10.1186/1471-244X-11-138

GUO C, SHI Z, REVINGTON P: Arthrocentesis and lavage for treating temporomandibular joint disorders. Cochrane Database Syst Rev 2009; 7(4): CD004973. https://doi.org/10.1002/14651858.cd004973.pub2

GURBUZ O, ALATAS G, KURT E: Prevalence of temporomandibular disorder signs in patients with schizophrenia. J Oral Rehabil 2009;36(12):864-71. https://doi.org/10.1111/j.1365-2842.2009.02008.x

HEDE B: Dental health behavior and self-reported dental health problems among hospitalized psychiatric patients in Denmark. Acta Odontol Scand 1995; 53 (1): 35-40. https://doi.org/10.3109/00016359509005942

JOHNSON NW, BAIN CA: Tobacco and oral disease. EU-Working group on tobacco and oral health. Br Dent J 2000; 189(4): 200-206. https://doi.org/10.1038/sj.bdj.4800721

KELTNER NL, GRANT JS: Smoke, smoke, smoke that cigarette. Perspect Psychiatr Care 2006; 42(4): 256-261. https://doi.org/10.1111/j.1745-6163.2006.00085.x

KUDOH A, KATAGAI H, TAKASE H, et al: Effect of preoperative discontinuation of antipsychotics in schizophrenic patients on outcome during and after anesthesia. Eur J Anaesth 2004;21(5):414–6. https://doi.org/10.1017/s026502150422511x

KUDOH A, KUDO T, ISHIHARA H, et al: Depressed pituitary-adrenal response to surgical stress in chronic schizophrenic patients. Neuropsychobiol 1997; 36 (3) :112–6. https://doi.org/10.1159/000119372

LANCTOT JL, BEST TS, MITTMANN N, et al: Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry 1998;59(10):550–61. https://doi.org/10.4088/jcp.v59n1010

MEYER JM: Treating the mind and body in schizophrenia: risks and prevention. CNS Spectr 2004; 9 (10 suppl 11): 25-33. https://doi.org/10.1017/s1092852900025104

NEELEY WW, KLUEMPER TG, HAYS LR: Psychiatry in orthodontics. Part 1: Typical adolescent psychiatric disorders and their relevance to orthodontic practice. Am J Orthod Dentofacial Orthop 2006; 129(2): 176-184. https://doi.org/10.1016/j.ajodo.2005.11.009

OLIN BR, HEBEL SK, DOMBEK CE: Drug facts and comparisons. 2007 (2007 ed.) St. Louis, Missouri, USA. Facts and Comparisons Inc. 2007.

Oral Health Care Guidelines American Dental Association, 1991. Patients with Physical and Mental Disabilities, May 1991.

PHILIPS M, SABAS M, GREENBERG J: Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol 1993; 46 (9): 861-64. https://doi.org/10.1136/jcp.46.9.861

PORTILLA MI, MAFLA AC, ARTEAGA JJ: Periodontal status in female psychiatric patients. Colombia Medica 2009; 40 (2): 167-176. https://doi.org/10.25100/cm.v40i2.639

PRINCE M, PATEL V, SAXENA S, et al: No health without mental health. Lancet 2007; 370(9590): 859-877. https://doi.org/10.1016/s0140-6736(07)61238-0

SCULLY C, CAWSON RA: Medical problems in dentistry. (3rd ed.), Oxford, Butterworth-Heinemann, 1993. 428-430.

SELWITZ RH, ISMAIL AI, PITTS NB: Dental caries. Lancet 2007; 369 (9555) 51-59. https://doi.org/10.1016/s0140-6736(07)60031-2

SONIS ST, FAZIO RC, FANG L: Principles and practice of oral medicine. (2nd ed.) Philadelphia, Saunders, 1995: 339-342.

STIEFEL DJ, TRUELOVE EL, MENARD TW, et al: A comparison of the oral health of persons with and without chronic mental illness in community settings. Spec Care Dentist 1990; 10 (1): 6-12. https://doi.org/10.1111/j.1754-4505.1990.tb01079.x

The International Association for Dental Research (IADR), Oral Diseases Related to Tobacco Use. https://www.iadr.org/AADR/About-Us/Policy-Statements/Science-Policy/Oral-Disease-Related-to-Tobacco-Use (2011.09.05).

THOMAS A, LAVRENTZOU E, KAROUZOS C, et al: Factors which influence the oral condition of chronic schizophrenia patients. Spec Car Dentist 1996; 16(2): 84-86. https://doi.org/10.1111/j.1754-4505.1996.tb00839.x

TOSELLO A, FOTI B, SEDARAT C, et al: Oral functional characteristics and gastrointestinal pathology: an epidemiological approach. J Oral Rehabil 2001; 28(7):668-672. https://doi.org/10.1046/j.1365-2842.2001.00730.x

World Health Organization, The world health report 2013

YAGIELA JA, DUFFIN SR, HUNT LM: Drug interactions and vasoconstrictors used in local anesthetic solutions. Oral Surg Oral Med Oral Pathol 1985; 59(6): 565-571. https://doi.org/10.1016/0030-4220(85)90181-1

YALTIRIK M, KOCAELLI H, YARGIC I: Schizophrenia and dental management: review of the literature. Quintessence Int 2004, 35(4):317-320. PMID: 15119719